Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CoreWeave, Inc. reported that Chief Financial Officer Nitin Agrawal sold 65,055 shares of Class A Common Stock on July 13, 2026 in a series of open‑market sales executed under a pre‑arranged Rule 10b5‑1 trading plan, at weighted average prices between $83.2595 and $88.2505 per share, with underlying trades occurring within price ranges from $82.80 to $88.79 per share as described in the footnotes.
Following these sales, Agrawal holds 128,716 shares directly and additional indirect interests, including 57,952 shares in a Yosemite 2025 GRAT, 81,000 shares in a Yellowstone 2025 GRAT, and 34,905 shares held by his spouse.
CRWV filed a Form 144 notice covering the proposed sale of 200000 shares of common stock, with an aggregate market value of $16662000.00, to be sold through Morgan Stanley Smith Barney LLC on or after 07/14/2026 on NASDAQ.
The shares to be sold were acquired on 02/25/2019 via a Preferred Stock Conversion from the issuer. Total common shares outstanding were 447573939; this is a baseline figure, not the amount being offered. The disclosure also lists numerous recent transactions, including Rule 10b5-1 sales by holders such as Michael Intrator and Omnadora Capital LLC.
A holder of CRWV common stock plans to sell 107,692 shares, with an indicated aggregate market value of $8,971,820.52, and sales expected to begin on 07/14/2026 on NASDAQ. These shares are described as founder shares acquired from the issuer on 11/13/2017.
The disclosure also lists numerous transactions over the past three months labeled as 10b5-1 Sales for Michael Intrator and Omnadora Capital LLC, including repeated 200,000-share and 107,692-share sales, along with one transaction for Fidelity Charitable.
CRWV received a notice of proposed sale of common stock under Rule 144. A holder plans to sell 25,000 common shares of CRWV through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $2,222,000.00 and listing on NASDAQ as of 07/13/2026.
The filing also lists extensive Rule 10b5-1 sales of CRWV common stock during the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, with individual transactions as large as 200,000 shares on single days under pre-arranged trading plans.
CRWV insiders filed a Form 144 to sell restricted common stock. The filing lists a proposed sale of 12,500 shares of common stock with an aggregate value of $1,111,000.00 through Morgan Stanley Smith Barney LLC Executive Financial Services, with the securities to be sold on 07/13/2026 on NASDAQ. The shares are identified as Founders Shares originally acquired on 02/25/2019 from the issuer.
The disclosure also details extensive Rule 10b5-1 sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, including multiple transactions of 144,000 shares for Brannin McBee and 200,000-share sales in April 2026, with individual transaction proceeds reaching into the tens of millions of dollars.
A shareholder of CRWV has filed a notice of proposed sale of up to 144,000 shares of common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services. The filing lists an aggregate market value for these shares of $12,798,720.00, with 447,573,939 common shares of the issuer stated as outstanding as of the filing. The shares are described as Founders Shares originally acquired on 02/25/2019.
The filing also details extensive Rule 10b5-1 sales of CRWV common stock during the past three months by Brannin McBee, Meghan Bennett, and several related trusts and entities. These include multiple block transactions, such as 200,000 shares sold on 04/20/2026 for total proceeds of $23,186,400.00, along with numerous additional sales in April, May, June, and early July 2026.
CRWV filed a Form 144 covering the proposed sale of 500 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $44,440.00, expected on July 13, 2026 on NASDAQ. The shares are identified as Founders Shares acquired on February 25, 2019. The filing also lists extensive prior Rule 10b5-1 plan sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett, and several related trusts, each showing specific dates, share amounts, and total sale prices.
CRWV shareholder Nitin Agrawal, through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed to sell common stock under Form 144. The notice lists 65,055 common shares with an aggregate market value of $5,782,088.40 on NASDAQ as of 07/13/2026. It also reports prior Rule 10b5-1 sales over the past three months, including 58,429 shares for $6,818,582.50 and 63,891 shares for $5,964,511.55, plus several smaller transactions.
CRWV stockholders filed a Form 144 indicating a proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $3,555,200.00, to be sold on NASDAQ on 07/13/2026.
The filing also lists extensive Rule 10b5-1 plan sales of CRWV common stock during the past three months by holders including Brannin McBee, Meghan Bennett, and several related trusts and entities, with multiple transactions in April, May, June, and early July 2026 involving blocks up to 200,000 shares and multi‑million‑dollar total values.
A stockholder of CRWV filed a notice of proposed sale on Form 144 covering 3,000 shares of common stock. The shares, originally acquired as Founders Shares on February 25, 2019, are slated for potential sale through Morgan Stanley Smith Barney LLC with an aggregate market value of $266,640.00 as of July 13, 2026 on NASDAQ. The filing also lists extensive Rule 10b5-1 share sales by related parties and trusts over the past three months, including multiple blocks of up to 200,000 shares of common stock.